Renaissance Technologies (RenTech)'s BBNX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 11,300 shares of Beta Bionics, Inc. (BBNX) worth $177,071, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 4 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in BBNX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 11,300 shares. Largest reduction occurred in Q4 2025, reducing 22,500 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Beta Bionics (BBNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beta Bionics (BBNX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +11,300 | New Buy | 11,300 | $15.67 |
| Q4 2025 | -22,500 | Sold Out | 0 | $0.00 |
| Q3 2025 | +6,000 | Add 36.36% | 22,500 | $19.87 |
| Q2 2025 | +16,500 | New Buy | 16,500 | $14.56 |
Renaissance Technologies (RenTech)'s Beta Bionics Investment FAQs
Renaissance Technologies (RenTech) first purchased Beta Bionics, Inc. (BBNX) in Q2 2025, acquiring 16,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Beta Bionics, Inc. (BBNX) for 4 quarters since Q2 2025.
Renaissance Technologies (RenTech)'s largest addition to Beta Bionics, Inc. (BBNX) was in Q2 2025, adding 16,500 shares worth $240,240.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 11,300 shares of Beta Bionics, Inc. (BBNX), valued at approximately $177,071.
As of the Q2 2026 filing, Beta Bionics, Inc. (BBNX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Beta Bionics, Inc. (BBNX) was 22,500 shares, as reported at the end of Q3 2025.